• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY Back to Search Results
Model Number 180343
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Edema (1820); Myocardial Infarction (1969); Nausea (1970); Vomiting (2144)
Event Date 04/09/2020
Event Type  Injury  
Manufacturer Narrative
Clinical review: a temporal relationship exists between ccpd therapy utilizing the liberty select cycler and the patient¿s adverse events of nausea, vomiting, and swelling/edema which warranted hospitalization and surgical intervention.The cause of the mi was attributed to the patient¿s cardiac history, and two occluded arteries which required stenting.The cause of the patient¿s nausea, vomiting and hypervolemic state is unknown; therefore, causality cannot be firmly established.However, given the patient¿s decreased cardiac output and lower extremity swelling/edema, it is reasonable to conclude the patient¿s hypervolemic state was, in part, caused by the patient¿s changes in cardiovascular health.Nevertheless, based on the limited information available, the liberty select cycler cannot be excluded from having a possible contributory role in the events.Given the events partially occurred during ccpd therapy, the lack of a discharge summary, no treatment data, no past medical history and no manufacturer investigation (device not returned) into the suspect device.There is insufficient evidence to substantiate a disassociation of the device from the events.Fluid overload and hypervolemia are common and often preventable processes.Many factors such as non-compliance, inappropriate prescription, loss of residual renal function, mechanical problems and peritoneal membrane failure are all possible contributing factors.The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event Description
A paramedic contacted fresenius technical support requesting assistance discontinuing continuous cyclic peritoneal dialysis (ccpd) for a patient.The paramedic reported the patient was going to be taken to the hospital.Follow-up with the patient and patient¿s daughter, revealed the patient was hospitalized from (b)(6) 2020 due to nausea, vomiting and a myocardial infarction (mi), which occurred during ccpd therapy on (b)(6) 2020.The patient experienced an mi due to ¿clogged arteries¿ (specifics not provided).The patient underwent a cardiac catheterization, where two stents were successfully placed.One of the patient¿s arteries was 99% occluded and another was 98% occluded (specifics not provided).The patient¿s daughter reported the patient was approximately 4.5 kgs above their estimated dry weight (dry weight not provided) and received two ccpd treatments utilizing primarily a 4.25% dextrose solution.The daughter had no knowledge if the patient was diagnosed with ¿fluid overload,¿ however the patient¿s lower extremities were visibly swollen.The patient was discharged and resumed ccpd therapy on the same liberty select cycler as before the events.Additional information was requested, however to date has not been provided.
 
Manufacturer Narrative
Plant investigation: no parts were returned to the manufacturer for physical evaluation.A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformance's, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the reported problem was not able to be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBERTY SELECT CYCLER ASSY(NON-VALUATED)
Type of Device
SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
Manufacturer (Section D)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
MDR Report Key9979046
MDR Text Key188643231
Report Number2937457-2020-00706
Device Sequence Number1
Product Code FKX
UDI-Device Identifier00840861102068
UDI-Public00840861102068
Combination Product (y/n)N
PMA/PMN Number
K181108
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup
Report Date 04/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Lay User/Patient
Device Model Number180343
Device Catalogue NumberRTLR180343
Was Device Available for Evaluation? No
Device AgeMO
Initial Date Manufacturer Received 04/09/2020
Initial Date FDA Received04/20/2020
Supplement Dates Manufacturer Received04/27/2020
Supplement Dates FDA Received04/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; LIBERTY CYCLER SET 
Patient Outcome(s) Hospitalization; Required Intervention;
-
-